Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Gastrointestinal Endoscopy|November 12, 2010
EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumorsMouen A Khashab, Elaine Yong, Anne Marie Lennon, et al.
JAMA Surgery|July 12, 2013
Missing consent forms in the preoperative area: a single-center assessment of the scope of the problem and its downstream effectsJacqueline M Garonzik-Wang, Gabriel Brat, Jose H Salazar, et al.
Cancer Immunology Research|February 13, 2026
Ex vivo expansion of melanoma tumor infiltrating lymphocytes leads to a dominant exhausted T cell population with lack of memory markersGianfilippo Coppola, Samuel Kerr, Pei-Chun Cha, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 14, 2009
Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosisJordan M Winter, John L Cameron, Kelly Olino, et al.
Indian Journal of Surgical Oncology|June 15, 2012
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancerHanno Matthaei, Seung-Mo Hong, Skye C Mayo, et al.
Journal of Surgical Oncology|December 1, 2022
Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanomaLaura D Leonard, Laurel Beaty, Madeline Thomas, et al.
Annals of Surgical Oncology|May 4, 2011
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancerHanno Matthaei, Seung-Mo Hong, Skye C Mayo, et al.
Plos One|May 17, 2011
Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancerLei Zheng, Kelly Foley, Lanqing Huang, et al.
Cancer Immunology Research|July 21, 2023
Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 ResistanceIrina Krykbaeva, Kate Bridges, William Damsky, et al.
Journal for Immunotherapy of Cancer|July 26, 2019
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanomaNicholas D Klemen, Melinda Wang, Paul L Feingold, et al.
Pageof 7